0

540359

PARMAX

img img img img
No Data Available

Parmax Pharma Limited Share Price Update

As of the latest trading session, Parmax Pharma Limited is trading at ₹37.01, down by ₹-2.95 or -7.38% from its previous close. The stock has moved between ₹36.10 and ₹39.96 today. Over the past year, the stock has delivered a return of -18.43%. In the last month, it has returned 19.45%.

Investment Returns

Over 1 Month 19.45% Over 3 Months 12.31% Over 6 Months 7.99% Over 1 Year -18.43%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Parmax Pharma Limited fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 13.90
  • P/E Ratio (TTM) -2.73
  • Beta -0.04
  • Book Value / share -14.81
  • Return on equity 0.00%
  • EPS (TTM) 0.00
  • Dividend yield [-]%
  • Net profit/quarter (Cr) -0.73
info icon alternate text

Parmax Pharma Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars DEC 2025 (Values in Cr)
Revenue 4.33
Operating Expense 5.07
Net Profit -0.73
Net Profit Margin (%) -16.85
Earnings Per Share (EPS) -1.96
EBITDA -0.17
Effective Tax Rate (%) 0.00
Particulars SEP 2025 (Values in Cr)
Revenue 2.53
Operating Expense 4.62
Net Profit -2.08
Net Profit Margin (%) -82.21
Earnings Per Share (EPS) -5.56
EBITDA -1.58
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 1.94
Operating Expense 2.71
Net Profit -0.76
Net Profit Margin (%) -39.17
Earnings Per Share (EPS) -2.04
EBITDA -0.24
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 4.83
Operating Expense 5.45
Net Profit -1.49
Net Profit Margin (%) -30.84
Earnings Per Share (EPS) -4.00
EBITDA -1.74
Effective Tax Rate (%) 16.66
Particulars DEC 2024 (Values in Cr)
Revenue 6.28
Operating Expense 6.70
Net Profit -0.39
Net Profit Margin (%) -6.21
Earnings Per Share (EPS) -1.05
EBITDA 0.12
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 28.20
Operating Expense 29.57
Net Profit -2.09
Net Profit Margin (%) -7.41
Earnings Per Share (EPS) -5.60
EBITDA -0.78
Effective Tax Rate (%) 12.50
Particulars MAR 2024 (Values in Cr)
Revenue 11.05
Operating Expense 16.76
Net Profit -5.75
Net Profit Margin (%) -52.03
Earnings Per Share (EPS) -15.37
EBITDA -3.33
Effective Tax Rate (%) -1.59
Particulars MAR 2023 (Values in Cr)
Revenue 15.42
Operating Expense 15.42
Net Profit -0.10
Net Profit Margin (%) -0.64
Earnings Per Share (EPS) -0.28
EBITDA 2.30
Effective Tax Rate (%) 299.99
Particulars MAR 2022 (Values in Cr)
Revenue 18.25
Operating Expense 18.01
Net Profit 0.14
Net Profit Margin (%) 0.76
Earnings Per Share (EPS) 0.38
EBITDA 2.62
Effective Tax Rate (%) 53.33
Particulars MAR 2021 (Values in Cr)
Revenue 26.20
Operating Expense 25.08
Net Profit 0.75
Net Profit Margin (%) 2.86
Earnings Per Share (EPS) 2.02
EBITDA 3.50
Effective Tax Rate (%) 37.19
Particulars MAR 2025 (Values in Cr)
Book Value / Share -4.47
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 1.06
Particulars MAR 2024 (Values in Cr)
Book Value / Share 0.24
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.90
EBITDA Margin -30.05
Particulars MAR 2023 (Values in Cr)
Book Value / Share 13.16
ROE % -1.69
ROCE % 3.76
Total Debt to Total Equity 0.89
EBITDA Margin 14.85
Particulars MAR 2022 (Values in Cr)
Book Value / Share 13.39
ROE % 2.38
ROCE % 6.04
Total Debt to Total Equity 0.94
EBITDA Margin 14.41
Particulars MAR 2021 (Values in Cr)
Book Value / Share 13.07
ROE % 13.79
ROCE % 14.26
Total Debt to Total Equity 1.02
EBITDA Margin 13.44
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.09
Total Assets 18.75
Total Liabilities 18.75
Total Equity -1.98
Share Outstanding 0
Price to Book Ratio -9.45
Return on Assets (%) -11.16
Return on Capital (%) -36.64
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 15.33
Total Liabilities 15.33
Total Equity 0.10
Share Outstanding 0
Price to Book Ratio 118.67
Return on Assets (%) -37.51
Return on Capital (%) -95.65
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.40
Total Assets 17.61
Total Liabilities 17.61
Total Equity 5.85
Share Outstanding 0
Price to Book Ratio 2.31
Return on Assets (%) -0.59
Return on Capital (%) -1.01
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.05
Total Assets 17.97
Total Liabilities 17.97
Total Equity 5.95
Share Outstanding 0
Price to Book Ratio 3.05
Return on Assets (%) 0.78
Return on Capital (%) 1.35
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.54
Total Assets 22.72
Total Liabilities 22.72
Total Equity 5.81
Share Outstanding 0
Price to Book Ratio 2.72
Return on Assets (%) 3.31
Return on Capital (%) 6.7
Particulars MAR 2025 (Values in Cr)
Net Income -2.39
Cash from Operations -0.95
Cash from Investing -0.70
Cash from Financing 1.39
Net change in Cash -0.26
Free Cash Flow -0.25
Particulars MAR 2024 (Values in Cr)
Net Income -5.65
Cash from Operations -0.19
Cash from Investing -1.58
Cash from Financing 1.42
Net change in Cash -0.35
Free Cash Flow 1.39
Particulars MAR 2023 (Values in Cr)
Net Income 0.04
Cash from Operations 0.33
Cash from Investing -0.93
Cash from Financing -0.04
Net change in Cash -0.64
Free Cash Flow 1.26
Particulars MAR 2022 (Values in Cr)
Net Income 0.30
Cash from Operations 0.74
Cash from Investing -1.53
Cash from Financing -0.91
Net change in Cash -1.69
Free Cash Flow 2.28
Particulars MAR 2021 (Values in Cr)
Net Income 1.20
Cash from Operations 3.52
Cash from Investing -3.14
Cash from Financing 0.39
Net change in Cash 0.77
Free Cash Flow 6.67
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 35.69 14.75 1.72 273.50 23.12 40.00
BLISS GVS PHARMA LTD. 424.80 34.37 3.76 4493.92 118.35 437.40
CIPLA LTD 1398.50 27.69 3.28 112970.91 1165.55 1672.20
FERMENTA BIOTECH LTD. 295.20 13.02 2.13 868.80 256.40 399.00
GLAXOSMITHKLINE PHARMA LT 2208.70 36.65 16.50 37416.71 2194.15 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 35.69 24.96 4.59 273.50 23.12 40.00
AMRUTAJAN HEALTH LTD 559.55 25.08 4.36 1617.69 490.00 789.95
ASTRAZENECA PHARMA IND LT 8671.45 113.25 24.83 21678.63 7630.00 10653.05
BLISS GVS PHARMA LTD. 424.80 45.68 3.89 4493.92 118.35 437.40

Parmax Pharma Limited shareholding pattern

Holding
69.19%
30.8%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Parmax Pharma Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
37.03 -7.33 redarrow
red-green-graph indicator
2 Bearish
14 Bullish
  • 5 Days 37.20
  • 26 Days 33.60
  • 10 Days 35.80
  • 50 Days 32.60
  • 12 Days 35.40
  • 100 Days 32.40
  • 20 Days 34.20
  • 200 Days 33.60
40.55 PIVOT
First Support 38.11 First Resistance 42.41 Second Support 36.25 Second Resistance 44.85 Third Support 33.81 Third Resistance 46.71
RSI 61.40 ADX 37.06 MACD 1.74 Williams % R -49.75 Commodity Channel Index (CCI) 136.20
Date 2026-05-29 Week 3054.00 Same Day 1055.00 Month 1830.00
1 Year -0.04 3 Year 0.18
Over 1 Month
19.45% down
Over 1 Year
-18.43% down
Over 3 Months
12.31% down
Over 3 Years
6.75% down
Over 6 Months
7.99% down
Over 5 Years
-8.58% down

Parmax Pharma Limited Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Parmax Pharma Ltd?

Answer Field

Parmax Pharma Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 37.03 as on May 29 2026 03:29 PM.

What is the Market Cap of Parmax Pharma Ltd Share?

Answer Field

The market cap of Parmax Pharma Ltd for NSE ₹ 0.00 & for BSE ₹ 13.90 as on May 29 2026 03:29 PM.

What is the 52 Week High and Low of Parmax Pharma Ltd?

Answer Field

The 52 Week High and Low of Parmax Pharma Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 46.57 and ₹ 22.60.

What is 1 year return for Parmax Pharma Ltd?

Answer Field

The 1 year returns on the stock has been -18.43%.

What is the P/E Ratio of Parmax Pharma Ltd Share?

Answer Field

As on May 29 2026 03:29 PM the price-to-earnings (PE) ratio for Parmax Pharma Ltd share is -2.73.

What is the PB ratio of Parmax Pharma Ltd Share?

Answer Field

As on May 29 2026 03:29 PM, the price-to-book (PB) ratio for Parmax Pharma Ltd share is -14.81.

How to Buy Parmax Pharma Ltd Share?

Answer Field

You can trade in Parmax Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Parmax Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Parmax Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Parmax Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|